February 25, 2021 -- The Hennessy Group, an executive search firm specializing in life sciences, announces the recent placement of Scott Waldman as Senior Vice President, Corporate Development at Albany Molecular Research, Inc. (AMRI), a leading contract research development and manufacturing company. AMRI is a portfolio company of The Carlyle Group and CTGR. Waldman will […]
Today, we released a new logo and website, expanding on our brand identity that began over 20 years ago when The Hennessy Group first opened for business. Since 1999, The Hennessy Group has been a leading boutique executive search firm serving the life sciences industry. We developed our logo to represent who we are, what […]
August 20, 2020 -- The Hennessy Group, an executive search firm specializing in life sciences, announced the recent placements of key executives at three leading biopharmaceutical companies. Paul Korner, MD, MBA, was placed as Chief Medical Officer with Agile Therapeutics, a cutting-edge women's healthcare company. In this new position, Dr. Korner will support the commercial launch […]
Aug 9, 2019 (Park City, UT) The Hennessy Group, an executive search firm specializing in the life sciences industry, announced the placement of new, key members of the science and leadership teams at Eloxx Pharmaceuticals and Amicus Therapeutics. Eloxx Pharmaceuticals has selected Dan Crawford to serve as its Principal Scientist for Pharmacology and Translational Sciences. […]
At my firm, we’ve known for a long time the value that experience earned at one pharmaceutical company can have on the next pharmaceutical company that hires an executive. It’s the primary reason why we keep such close tabs on the candidates we connect with and the ones we place. We try to maintain these […]
Jun 1, 2019 -- Boutique executive search consultants, The Hennessy Group, recently celebrated the start of its 20th year of service in the life sciences industry. “We couldn’t be more excited,” says founder and CEO Robert D. Hennessy. “When I started this company in 1999, I could only dream about this kind of longevity. I […]
How many boards can an experienced director participate on and still remain effective? I’ve known (and placed) brilliant board members and directors and realize that most are quite adept at performing the role for more than a single organization. But is there an upper-end limit? In the life sciences industry, the goal is to save […]
When I consult executive candidates, I often need to encourage them to think outside the box in terms of their career. There's not a single path that works for everyone and rarely is it a straight-line trajectory to the top. All told, I'd say it's working. We keep close tabs on the successes of our […]
We have a pretty good idea of what motivates a leader in the life sciences industry to move to a new opportunity because we hear it directly from them during interviews. But most of our discussions are informal. We decided it was time to get a more official temperature on what drives executive candidates, particularly […]
From Endpoint News, January 16, 2019. Blocking PD-L1 production in mice, UCSF team spotlights preclinical promise of a Pfizer-backed I/O drug
